Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H16O4 |
| Molecular Weight | 284.3065 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(\C=C\C(=O)OCCC2=CC=CC=C2)C=C1O
InChI
InChIKey=SWUARLUWKZWEBQ-VQHVLOKHSA-N
InChI=1S/C17H16O4/c18-15-8-6-14(12-16(15)19)7-9-17(20)21-11-10-13-4-2-1-3-5-13/h1-9,12,18-19H,10-11H2/b9-7+
| Molecular Formula | C17H16O4 |
| Molecular Weight | 284.3065 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL5983 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22236472 |
80.0 nM [IC50] | ||
Target ID: CHEMBL4681 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22506594 |
1.7 µM [IC50] | ||
Target ID: CHEMBL3471 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7473544 |
7.0 µM [IC50] | ||
Target ID: CHEMBL215 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29953727 |
1.01 µM [IC50] | ||
Target ID: map04210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28926932 |
27.84 µM [IC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cytotoxic and apoptotic effects of leptocarpin, a plant-derived sesquiterpene lactone, on human cancer cell lines. | 2015-12-05 |
|
| Transcriptional Regulation of the Sodium-activated Potassium Channel SLICK (KCNT2) Promoter by Nuclear Factor-κB. | 2015-07-24 |
|
| Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness. | 2014-04-25 |
|
| Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. | 2013-12-15 |
|
| Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. | 2013-10 |
|
| Caffeic acid phenethyl ester inhibits diesel exhaust particle-induced inflammation of human middle ear epithelial cells via NOX4 inhibition. | 2013-09 |
|
| Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis. | 2013-06-20 |
|
| Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus. | 2013 |
|
| Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. | 2013 |
|
| Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis. | 2012-04 |
|
| A pharmacologically-based array to identify targets of cyclosporine A-induced toxicity in cultured renal proximal tubule cells. | 2012-01-15 |
|
| The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo. | 2011-12 |
|
| The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase. | 2011-07-15 |
|
| Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells. | 2011-01-01 |
|
| Caffeic acid phenethyl ester suppresses the production of adipocytokines, leptin, tumor necrosis factor -alpha and resistin, during differentiation to adipocytes in 3T3-L1 cells. | 2011 |
|
| Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells. | 2010-12-05 |
|
| Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines. | 2010-10-06 |
|
| Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats. | 2010-08 |
|
| Inhibitory effect of caffeic acid phenethyl ester on mice bearing tumor involving angiostatic and apoptotic activities. | 2010-07-30 |
|
| p52-Bcl3 complex promotes cyclin D1 expression in BEAS-2B cells in response to low concentration arsenite. | 2010-06-29 |
|
| Structure-activity relationships in the cytoprotective effect of caffeic acid phenethyl ester (CAPE) and fluorinated derivatives: effects on heme oxygenase-1 induction and antioxidant activities. | 2010-06-10 |
|
| An approach to the study of gene expression in hepatocarcinogenesis initiation. | 2010-04 |
|
| Effects of caffeic acid phenethyl ester on endotoxin-induced cardiac stress in rats: a possible mechanism of protection. | 2009-10-01 |
|
| Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines. | 2008-12-15 |
|
| Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells. | 2008-11 |
|
| Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. | 2008-10 |
|
| Evidence that the anticarcinogenic effect of caffeic acid phenethyl ester in the resistant hepatocyte model involves modifications of cytochrome P450. | 2008-07 |
|
| Protective effect of caffeic acid phenethyl ester against carbon tetrachloride-induced hepatotoxicity in mice. | 2008-06-03 |
|
| Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. | 2007-05 |
|
| Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor kappaB responses and cell death are altered by caffeic acid phenethyl ester: a potential role for antioxidant/electrophilic response-element signaling. | 2007-04 |
|
| A single dose of caffeic acid phenethyl ester prevents initiation in a medium-term rat hepatocarcinogenesis model. | 2006-11-14 |
|
| Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells. | 2006-10-01 |
|
| Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo. | 2006-03-28 |
|
| The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester. | 2006-02-01 |
|
| The novel cytokine p43 induces IL-12 production in macrophages via NF-kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells. | 2006-01-01 |
|
| Arsenite enhances tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1. | 2005-11-15 |
|
| PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism. | 2005-10-15 |
|
| Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells. | 2005-09-15 |
|
| Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. | 2005-06-15 |
|
| Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet. | 2005 |
|
| Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. | 2004-12 |
|
| IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. | 2004-10-01 |
|
| Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. | 2004-10 |
|
| Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins. | 2004-08 |
|
| Design and synthesis of novel dihydroxyindole-2-carboxylic acids as HIV-1 integrase inhibitors. | 2004-03 |
|
| Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats. | 2004-01-28 |
|
| HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. | 1997-03-14 |
|
| Hydroxylated aromatic inhibitors of HIV-1 integrase. | 1995-10-13 |
|
| Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. | 1994-08-03 |
|
| Inhibitors of human immunodeficiency virus integrase. | 1993-03-15 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:22:46 GMT 2025
by
admin
on
Mon Mar 31 19:22:46 GMT 2025
|
| Record UNII |
G960R9S5SK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
3202 (Number of products:3)
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
||
|
NCI_THESAURUS |
C2189
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID8040987
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
104594-70-9
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
8062
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
C055494
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
C63756
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
Caffeic acid phenethyl ester
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
G960R9S5SK
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY | |||
|
5281787
Created by
admin on Mon Mar 31 19:22:46 GMT 2025 , Edited by admin on Mon Mar 31 19:22:46 GMT 2025
|
PRIMARY |